1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
620277F72AF8980DC002585E5003C2395
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/20277F72AF8980DC002585E5003C2395?OpenDocument
18
19OpenDocument
203.237.254.197
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB






Products & Services >> Best Practice Database >>Archived Research Alerts >>August 2020 Research

AUGUST 2020 Research Alert

This month we added four new studies to the Best Practice Database, the research repository for Best Practices, LLC. This month's new studies focus on three topical areas: A case study examining use of comparative effectiveness data in Skyrizi; MSLs and sharing on-label data; and Medical Affairs role in hematology launches. The first study examines how AbbVie used comparative effectiveness data to position its launch of Skyrizi. The second new document deals with MSLs and sharing on-label data. The last two studies present a look at the role of Medical Affairs in the launch of hematology products, including activities, timelines and resources.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.


Download: Skyrizi Case Study: Developing Early Comparative Effectiveness and Outcomes Studies to Lift Launch Uptake Curve and Accelerate Planned Obsolescence of AbbVie's Own Blockbuster (5625)

Best Practices LLC developed this case study through extensive secondary research to showcase how AbbVie used early comparative effectiveness and outcome studies to lift Skyrizi’s launch uptake curve and accelerate planned obsolescence of its own blockbuster Humira.


Download: MSL Engagements Related to On-Label Data (5626)

This study provides pharma companies with current trends on guidelines for scientific interactions with HCPs and thought-leaders. The study also touches on ensuring that such engagements occur in a compliant manner.


Download: Maximizing the Impact of Medical Affairs in Hematology Product Launches: Role and Activities (5627)

This benchmarking research explores how Medical Affairs can maximize its hematology launch impact. The study provides insights and benchmarks around strategy planning, role, activities, cross-functional alignment and collaboration for an effective hematology launch.


Download: Maximizing the Impact of Medical Affairs in Hematology Product Launches: Timeline, Resources, and Preparedness (5628)

This study provides insights and benchmarks around medical staffing, budgeting, timeline, preparedness metrics, tools and technology for an effective hematology launch. It also highlights the critical success factors and pitfalls for Medical Affairs during hematology launch.